Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
Shuang Zhang(Nanjing Medical University), Jiahong Lu(University of Macau)
Cited by 32
Related Papers
Autophagy for Cancer Therapy through Inhibition of Pro-apoptotic Proteins and Mammalian Target of Rapamycin Signaling
|Journal of Biological Chemistry|2006|178
l-cysteine-modified chiral gold nanoparticles promote periodontal tissue regeneration
|Bioactive Materials|2021|64
NVP-BEZ-235 enhances radiosensitization via blockade of the PI3K/mTOR pathway in cisplatin-resistant non-small cell lung carcinoma.
|Genes & Cancer|2014|44
Toosendanin, a novel potent vacuolar-type H<sup>+</sup>-translocating ATPase inhibitor, sensitizes cancer cells to chemotherapy by blocking protective autophagy
|International Journal of Biological Sciences|2022|41
Enhancement of efferocytosis through biased FPR2 signaling attenuates intestinal inflammation
|EMBO Molecular Medicine|2023|35